US mRNA specialist Moderna has announced that the UK Court of Appeal has upheld the validity of its EP'949 patent.

US biotech major Biogen (Nasdaq: BIIB) reported a 7% rise in its second quarter revenue Friday, with sales of $2.45 billion.

US Biotech Regeneron Pharmaceuticals today announced financial results for the second quarter of 2025 and provided a business ...

For the first time in decades, the pharmaceutical industry has been directly affected by a geopolitical trade negotiation ...

US mRNA specialist Moderna has today reported financial results and provided business updates for the second quarter of 2025, ...

US President Donald Trump has sent letters to leading pharmaceutical manufacturers outlining the steps they must take to ...

Frazier Life Sciences (FLS), a US investment firm focused on innovative therapeutics, has announced the closing of its ...

The US Food and Drug Administration (FDA) is requiring safety labeling changes to all opioid pain medications to better ...

CSL Behring, a part of Australia’s’ CSL Limited, today announced that the board of directors of the Italian Medicines Agency ...

Esteve CDMO (Esteve Química) - part of privately-held Spanish drugmaker Lab Esteve - has acquired Regis Technologies, a ...

US pharma major Eli Lilly has announced top-line results from SURPASS-CVOT, a first-of-its-kind head-to-head Phase III ...

Bristol Myers Squibb (NYSE: BMY) has posted better-than-expected second-quarter 2025 results, driven by strong sales of its ...